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Abstract
Background: Osteomyelitis is a challenge for orthopaedic surgeons. There is a lack of scientific evidence to guide
treatment. The purpose of this study was to report the clinical outcome of unplanned retention of antibiotic-
impregnated cement spacer (ACS) in the management of osteomyelitis.
Methods: Eight patients (7 with tibial infections and 1 with a calcaneal infection) with osteomyelitis received
radical debridement and insertion of an ACS into the bone defect as the definitive management. The mean follow-
up period was 2 years (6 months to 4 years). All of these patients had a cement spacer in place.
Results: No patient exhibited radiographic evidence of excessive bone loss. The patients reported no or occasional
mild pain and exhibited complete weight-bearing abilities, with the exception of one patient who required a crutch
because of a spinal cord injury. Signs of recurrence of the osteomyelitis were not noted in any of the patients, and
no fractures occurred at last follow-up.
Conclusion: Our study suggests that a proportion of patients with unplanned retention of ACS appear to function
well without necessarily requiring further surgical intervention.
Background
Osteomyelitis is a challenge for orthopaedic surgeons.
The management of osteomyelitis has received minimal
attention, and there is a lack of scientific evidence to
guide treatment. Basically, a palliative or a curative ap-
proach must be decided. Interdisciplinary treatment with
close collaboration between trauma surgeons, plastic
surgeons, anaesthetists, microbiologists and radiologists
is essential for successful management of osteomyelitis
[1]. Curative management of osteomyelitis requires
aggressive surgical debridement and reconstruction
followed by antibiotic therapy. Soft tissue coverage and
dead space management after extensive debridement is
paramount because dead spaces may contribute to infec-
tion recurrence. All efforts should be made to optimize
the host prior to treatment, such as smoking cessation
and close control of blood glucose in patients with dia-
betes mellitus [2, 3].
If a curative approach is chosen, most of the patients
with osteomyelitis receive two-stage management in our
centre. The first stage includes radical debridement and
insertion of an antibiotic-impregnated cement spacer
(ACS) into the bone defect. The bone is stabilized, and
soft tissue is repaired if needed. The second stage is per-
formed 6 to 8 weeks later. The spacer is removed; a can-
cellous autograft is placed within the bone defect.
During our practice, eight patients with osteomyelitis
received only first-stage treatment due refusal of second-
stage treatment or patients were medically unfit without
major complications. The possibility of ACS as definitive
management for osteomyelitis is promising.
Although reports have been published on the long-
term use of ACS in infected total hip replacements
[4, 5], total knee replacements [6], total shoulder re-
placements [7, 8], total ankle replacements [9] and
diabetic feet [10, 11], similar studies are not available
on the use of ACS as a permanent solution for osteo-
myelitis. Therefore, the purpose of this study was to
evaluate the outcome of using ACS as a definitive
management for osteomyelitis.
Methods
Between January 2011 and June 2014, a total of 38 pa-
tients with osteomyelitis were treated at our institution
using the described technique. Eight of the 38 patients
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(six men, two women) received only the first-stage treat-
ment. These patients did not receive the second-stage
procedure because they were either medically unfit
(n = 2) or refused revision surgery (n = 6). Of these
patients, 7 had tibial infections (4 proximal, 1 shaft,
and 2 distal), and 1 had a calcaneal infection. The patients
underwent an average of 2 (range, 0 to 4) operations be-
fore referral to our centre. The delay between the occur-
rence of the bone infection and the treatment of bone
infection at our institution ranged from 10 to 700 days
(mean, 120 days). Detail patient information based on the
“Seven-Item Comprehensive Classification System” for
osteomyelitis is presented in Table 1 [12]. All patients
were treated by the senior author (CYX). The mean age at
the time of the first stage of reconstruction was 40.5
(range, 25 to 70) years.
Preoperative diagnosis of infection was made accord-
ing to clinical, laboratory, imaging, microbiological, and
pathohistological features. A history of sudden onset of
pain, swelling, or wound drainage with or without fever
and clinical findings of tenderness, warmth and effusion
were indicative of infection (Fig. 1). Laboratory tests in-
cluded white blood cell counts, erythrocyte sedimenta-
tion rate (ESR), and C-reactive protein (CRP) levels. An
ESR of greater than 15 mm/h together with a CRP of
greater than 8 mg/L is suggestive of infection. When an
effusion was palpable, aspiration under sterile conditions
was performed. The fluid was then sent for culture to
aid in making a definitive diagnosis as well as deciding
on the appropriate antibiotic to mix with the cement at
the time of surgery.
Initially, all eight patients planned to receive a two-
stage treatment. The first stage involved treating the
bone infection, and the second stage involved recon-
structing the bone defect. Initially, any internal bone fix-
ations were removed. Deep tissue samples were obtained
for microbiological analysis. After thorough soft tissue
and bone debridement, all patients’ bones were relatively
stable, and no stabilization with external fixators or
other device was needed. The bone defect was then filled
with antibiotic cement spacer (Fig. 1). Polymethyl
methacrylate (PMMA) bone cement (Smith & Nephew,
TN, USA) was used. We added additional sensitive anti-
biotics to the powder before mixing the powder and li-
quid (Table 2). If no culture was available, one gram of
vancomycin and one gram of gentamycin were mixed
into the cement (40 g). The volume of the bone defect
was estimated from the volume of filled cement spacer.
After thorough debridement, two patients needed soft
tissue reconstruction. Our plastic surgery colleagues
assisted with those cases requiring cutaneous/fasciocuta-
neous flaps for soft-tissue coverage.
Postoperatively, patients were initially treated with
sensitive antibiotics intravenously according to previous
culture result. Then, the antibiotics were adjusted ac-
cording to the deep tissue culture results. If the culture
was negative, the patient received vancomycin intraven-
ously. Antibiotic treatment lasted until CRP was less
than 8 mg/L and ESR was less than 15 mm/h. The pa-
tients were allowed full weight-bearing movement once
the wound was healed. All patients were evaluated post-
operatively every 1 to 2 months.
After resolution of the infection, the patients in this
study were either medically unfit (n = 2) or refused revi-
sion surgery (n = 6). Thus, the cement spacer was used
as a definitive procedure.
All patients provided informed consent for inclusion
in the study and consent was obtained from Case 3 pa-
tient for publication of individual information and ac-
companying images. The study was authorized by the
Medical Ethics Committee of Nanjing Drum Tower
Hospital and was performed in accordance with the eth-
ical standards of the 2013 Declaration of Helsinki.
Results
Deep tissue cultures obtained during the surgery were
positive in 7 patients, revealing the presence of Staphylo-
coccus aureus (n = 3), Staphylococcus epidermidis (n = 1),
Pseudomonas aeruginosa (n = 1), Acinetobacter bauman-
nii (n = 1), Escherichia coli (n = 1), Enterobacter cloacae
(n = 1), and Enterococcus avium (n = 1) (Table 2). One
patient whose culture was negative received vancomycin;
Table 1 Detailed patient information according to the “Seven-Item Comprehensive Classification System” for osteomyelitis
Cases Clinical presentation Aetiopathogenesis Anatomical pathology Host type/age Microorganism Bone defect Soft tissue defect
1 Delayed Temporary implant (type 2) Long bone (Stage 3) Aa Gram+ 1 2 (1 cm2)
2 Chronic Trauma Long bone (Stage 3) Ba Mixed flora 1 0
3 Subacute Haematogenous Long bone (Stage 3) Ba Gram- 1 0
4 Chronic Trauma Long bone (Stage 3) Aa Negative 1 1 (2 cm2)
5 Acute Trauma Foot Ba Gram+ 1 1 (1 cm2)
6 Chronic Trauma Long bone (Stage 3) Aa Mixed flora 1 1 (4 cm2)
7 Chronic Trauma Long bone (Stage 3) Aa Gram- 1 0
8 Chronic Trauma Long bone (Stage 3) Aa Gram+ 1 0
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other patients received sensitive antibiotics from the
cultures.
All patients exhibited partial segmental bone defects
[1] after debridement. The estimate volumes of bone de-
fects were 75 cm3 (40–110 cm3). One patient had super-
ficial wound breakdown early after surgery, which healed
with local wound care. The remaining seven patients
had no wound problems immediately after the surgery.
All flaps healed uneventfully. The mean hospital stay
was 21 (range, 14 to 31) days.
At a mean of 2 years (6 months to 4 years) follow-up,
all patients had the cement spacer in place. No patient
had radiographic evidence of excessive bone loss (Fig. 2).
The patients had no or occasional mild pain and did not
use pain medication on a daily basis. Patients exhibited
complete weight-bearing mobility and were able to per-
form their basic daily activities (Fig. 2), with the excep-
tion of one patient who used a crutch due to a spinal
cord injury associated with spinal fracture. No case had
any sign of recurrence of the osteomyelitis; no fractures
were noted at the last follow-up (Fig. 2).
Discussion
The management of chronic osteomyelitis is complicated
and relies on a multidisciplinary approach, consisting of
infection control with radical debridement, bone
stabilization in the case of non-union or bone segment
excision, local and systemic antibiotic therapy, dead
space and wound management and a bone graft of non-
united bone or large bone defects [13]. The main goals
are elimination of infection and promotion of bone
union. In the present study, all patients with osteomye-
litis planned to receive a two-stage management proced-
ure in our centre. The first stage involved radical
debridement and insertion of an ACS into the bone de-
fect. After debridement, all patients’ bones were rela-
tively stable, and no stabilization was needed. Soft tissue
was repaired in two patients. The second stage involving
cement spacer removal and bone grafting was planned 6
to 8 weeks later. However, all of the patients did not re-
ceive the second stage reconstruction and retained the
bone cement. At the last follow-up, these patients
Fig. 1 Case 3 (female, 70 years old) required long-term glucocorticoid treatment because of interstitial pneumonia. She suffered from left tibia
osteomyelitis and failed treatment with intravenous antibiotic therapy. a Tenderness, warmth and effusion were observed on admission one
month after the onset of osteomyelitis. d-e X-ray film and CT scan revealed bone destruction on admission. b, f hrough debridement was
performed; a significant bone defect occurred after debridement. c, g The bone defect was filled with bone cement
Table 2 Culture results and local antibiotics used
Cases Microorganism Local antibiotics/40 g cement
1 Staphylococcus aureus 1 g vancomycin
2 Enterobacter cloacae,
Enterococcus avium
1 g vancomycin/1 g imipenem
3 Escherichia coli 1 g imipenem
4 - 1 g vancomycin/1 g gentamycin
5 Staphylococcus aureus 1 g vancomycin
6 Staphylococcus aureus,
Pseudomonas aeruginosa
1 g vancomycin/1 g imipenem
7 Acinetobacter baumannii 1 g imipenem
8 Staphylococcus epidermidis 1 g vancomycin
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appeared to function well without necessarily requiring
further surgical intervention.
The long-term use of cement spacers have been re-
ported in periprosthetic joint infections and diabetic feet
[5, 6, 8–11]. Choi et al. [6] reported eighteen patients
with periprosthetic joint infection (11 hips and 7 knees)
treated by prosthetic articulating spacers who retained
their spacers and were followed up an average of
43.8 months (range, 13 to 78 months). Their study sug-
gested that a proportion of patients with unplanned re-
tention of prosthetic spacers appear to function well up
to 6 years. Haddad et al. [8] used ACS as a definitive
treatment for a patient with post-arthroscopy shoulder
destructive osteomyelitis. The patient maintained excel-
lent function with no radiological signs of wear or loos-
ening 4 years after surgery. Ferrao et al. [9] reported
using ACS as definitive management for postoperative
ankle infection in nine patients. The average time of ce-
ment spacer retention was 20.1 months (range, 6 to
62 months). At the final follow-up, seven patients still
retained their cement spacer, and two had below knee
amputations because of delayed complications. All pa-
tients with a retained cement spacer were mobile and
able to perform daily activities with minimal discomfort.
Melamed et al. [10] reported osteomyelitis and associ-
ated severe infection of forefoot joints in 20 patients
with diabetic neuropathy. Extensive debridement and
ACS was used in these patients. Of these patients,
91.3 % healed, and two required toe amputation. Cement
spacers permanently remained in 10 patients, were re-
moved with arthrodesis in six patients, and removed
without arthrodesis in five patients. The author con-
cluded that severe infection associated with osteomye-
litis of the foot in diabetic patients was successfully
treated with extensive debridement and the use of ACS.
To our knowledge, no reports about the long-term use
of ACS in patients with osteomyelitis in long bone are
available. Our study was the first report the long-term
use of ACS in patients with osteomyelitis in long bones.
Consistent with previous periprosthetic joint infection
reports, our study also revealed satisfactory clinical out-
comes. No patient had evidence of excessive bone loss
radiographically. The patients exhibited complete
weight-bearing mobility and were able to perform their
daily activities. No case exhibited any sign of recurrence
of the osteomyelitis; and no fractures occurred.
Bone resorption is a potential issue associated with the
retention of a temporary spacer. Recently, Regis et al. [5]
reported one case with 6 years of follow-up for a
retained ACS for the management of chronically in-
fected total hip replacement. Although the patient recov-
ered a good range of motion and was able to walk pain
free with assisted weight bearing, a slowly progressive
resorption of the cortical femur around the stem and fa-
tigue fracture of the stem of the spacer (at 2 years) were
observed. Therefore, these researchers suggested that
prolonged spacer implantation was not appropriate as a
permanent solution for septic hip replacement, and care-
ful periodic monitoring was required. In the present
study, no obvious bone loss was observed radiographic-
ally. Two factors potentially account for this observation.
First, the duration of follow-up was relatively short in
our study. Second, the retained cement spacer in the
joint was mobilisable, whereas the cement spacer in our
study was immobilisable.
Another common concern about the retained ACS is
that the long-term exposure to low dose antibiotics from
bone cements in patients is strongly related to the emer-
ging threat of antibiotic resistance [14]. Anagnostakos et
al. [15] evaluated this problem by examining 18 chains
Fig. 2 a-b At the 3-year follow-up, no excessive bone loss was observed on X-ray film and CT scan. c The patient achieved complete weight-
bearing ability without pain; no sign of recurrence of the infection was observed. d The patient exhibited normal range of motion of the
affected knee
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of antibiotic-loaded beads that were implanted for the
treatment of orthopaedic infections. In 4 cases, persist-
ent bacterial growth was noted on the beads. The emer-
gence of a gentamicin-resistant S. epidermidis strain was
noted in one case despite the fact that preoperative sam-
ples of S. epidermidis from this patient were susceptible
to the antibiotic. Their study reveals that the persistence
of bacterial growth on bone cement remains a hazardous
problem and that adherence of bacteria to cement can
lead to the emergence of antibiotic-resistant bacteria,
possibly resulting in clinical recurrence of the infection.
However, we believe that inadequate debridement is the
main cause for recurrence. The present study demon-
strated satisfactory infection control (100 %) with this
type of spacer, which is consistent with previous peri-
prosthetic joint infection reports [4, 6–9]. This result
may be attributed to the thorough debridement.
In summary, we report on the fate of retained cement
spacers in the management of osteomyelitis. Although
retention of temporary spacers is not the standard man-
agement and would not be appropriate in all cases of
osteomyelitis, our study suggests that some of these
retained spacers may have good clinical outcomes due to
satisfactory infection control and limb function. A fur-
ther prospective study is required to identify the factors
that contribute to the successful application of this
technique.
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